Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter L Anderson

Showing results (61-70 of 270) with videos related to

Pageof 27
Sort By:
The Journal of Antimicrobial Chemotherapy|May 28, 2014
Tenofovir diphosphate concentrations and prophylactic effect in a macaque model of rectal simian HIV transmissionPeter L Anderson, David V Glidden, Lane R Bushman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 4, 2024
Cumulative Tenofovir Exposure Among Patients With HIV/Hepatitis B Coinfection With Differential Viral SuppressionHelen L Zhang, Meredith Mock, Lane Bushman, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 11, 2006
Liquid chromatography-tandem mass spectrometric determination of tenofovir-diphosphate in human peripheral blood mononuclear cellsTracy King, Lane Bushman, Jennifer Kiser, et al.
Antimicrobial Agents and Chemotherapy|April 16, 2014
Cefoxitin continuous infusion for lung infection caused by the Mycobacterium abscessus groupChristopher A Czaja, Adrah Levin, Majid Moridani, et al.
Analytical and Bioanalytical Chemistry|February 16, 2022
Miniature mass spectrometer-based point-of-care assay for cabotegravir and rilpivirine in whole bloodSangeeta Pandey, Yanyang Hu, Lane R Bushman, et al.
Current HIV/AIDS Reports|May 20, 2020
Approaches to Objectively Measure Antiretroviral Medication Adherence and Drive Adherence InterventionsMatthew A Spinelli, Jessica E Haberer, Peter R Chai, et al.
The Journal of Antimicrobial Chemotherapy|December 2, 2010
Pharmacological considerations for tenofovir and emtricitabine to prevent HIV infectionPeter L Anderson, Jennifer J Kiser, Edward M Gardner, et al.
Hepatology (Baltimore, Md.)|January 23, 2016
Novel quantification of tenofovir disoproxil fumarate adherence in human immunodeficiency virus/hepatitis B coinfected patients with incomplete hepatitis B virus viral suppressionTammy C Wong, Audrey Lan, Jennifer J Kiser, et al.
AIDS Research and Human Retroviruses|March 8, 2012
A population pharmacokinetic-pharmacogenetic analysis of atazanavirDeidre A Kile, Samantha MaWhinney, Christina L Aquilante, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 10, 2008
Clinical and genetic determinants of intracellular tenofovir diphosphate concentrations in HIV-infected patientsJennifer J Kiser, Christina L Aquilante, Peter L Anderson, et al.
Pageof 27

Showing results (61-70 of 270) with videos related to

Sort By:
Pageof 27
The Journal of Antimicrobial Chemotherapy|May 28, 2014
Tenofovir diphosphate concentrations and prophylactic effect in a macaque model of rectal simian HIV transmissionPeter L Anderson, David V Glidden, Lane R Bushman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 4, 2024
Cumulative Tenofovir Exposure Among Patients With HIV/Hepatitis B Coinfection With Differential Viral SuppressionHelen L Zhang, Meredith Mock, Lane Bushman, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 11, 2006
Liquid chromatography-tandem mass spectrometric determination of tenofovir-diphosphate in human peripheral blood mononuclear cellsTracy King, Lane Bushman, Jennifer Kiser, et al.
Antimicrobial Agents and Chemotherapy|April 16, 2014
Cefoxitin continuous infusion for lung infection caused by the Mycobacterium abscessus groupChristopher A Czaja, Adrah Levin, Majid Moridani, et al.
Analytical and Bioanalytical Chemistry|February 16, 2022
Miniature mass spectrometer-based point-of-care assay for cabotegravir and rilpivirine in whole bloodSangeeta Pandey, Yanyang Hu, Lane R Bushman, et al.
Current HIV/AIDS Reports|May 20, 2020
Approaches to Objectively Measure Antiretroviral Medication Adherence and Drive Adherence InterventionsMatthew A Spinelli, Jessica E Haberer, Peter R Chai, et al.
The Journal of Antimicrobial Chemotherapy|December 2, 2010
Pharmacological considerations for tenofovir and emtricitabine to prevent HIV infectionPeter L Anderson, Jennifer J Kiser, Edward M Gardner, et al.
Hepatology (Baltimore, Md.)|January 23, 2016
Novel quantification of tenofovir disoproxil fumarate adherence in human immunodeficiency virus/hepatitis B coinfected patients with incomplete hepatitis B virus viral suppressionTammy C Wong, Audrey Lan, Jennifer J Kiser, et al.
AIDS Research and Human Retroviruses|March 8, 2012
A population pharmacokinetic-pharmacogenetic analysis of atazanavirDeidre A Kile, Samantha MaWhinney, Christina L Aquilante, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 10, 2008
Clinical and genetic determinants of intracellular tenofovir diphosphate concentrations in HIV-infected patientsJennifer J Kiser, Christina L Aquilante, Peter L Anderson, et al.
Pageof 27